HF
MRNA icon

HRT Financial’s Moderna MRNA Stock Holding History

HRT Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Buy
+9,200
New +$429K ﹤0.01% 2579
2025
Q2 		– Sell
-146,800
Closed -$4.16M – 3226
2025
Q1 		$4.16M Buy
146,800
+2,500
+2% +$88.7K 0.03% 512
2024
Q4 		$6M Buy
+144,300
New +$6.9M 0.03% 346
2024
Q3 		– Sell
-15,400
Closed -$1.83M – 2866
2024
Q2 		$1.83M Buy
+15,400
New +$1.95M 0.01% 771
2023
Q4 		– Sell
-13,600
Closed -$1.4M – 2800
2023
Q3 		$1.4M Buy
13,600
+10,400
+325% +$1.16M 0.01% 801
2023
Q2 		$388K Buy
+3,200
New +$427K ﹤0.01% 1479
2023
Q1 		– Sell
-8,600
Closed -$1.54M – 2930
2022
Q4 		$1.54M Buy
8,600
+6,600
+330% +$1.08M 0.02% 717
2022
Q3 		$236K Buy
+2,000
New +$303K ﹤0.01% 2143
2022
Q2 		– Sell
-8,000
Closed -$1.38M – 3411
2022
Q1 		$1.38M Sell
8,000
-5,600
-41% -$943K 0.01% 829
2021
Q4 		$3.45M Buy
+13,600
New +$3.98M 0.02% 409
2021
Q3 		– Sell
-43,000
Closed -$10.1M – 3592
2021
Q2 		$10.1M Buy
43,000
+2,100
+5% +$375K 0.09% 180
2021
Q1 		$5.36M Buy
40,900
+26,900
+192% +$3.9M 0.05% 276
2020
Q4 		$1.46M Buy
+14,000
New +$1.42M 0.03% 439

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's MRNA Position: Q1 2026 in Review

HRT Financial opened a new position in Moderna (MRNA) in Q1 2026: 368,421 shares worth $18.7M. The stake represents 0.05% of the portfolio and ranks #357 among its holdings. This is a return to the name: HRT Financial previously reported a position in MRNA as recently as Q3 2025.

HRT Financial first reported a position in MRNA in Q3 2020 and has held it in 11 quarters since. The position peaked at $140M in Q2 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • HRT Financial held 368,421 shares of Moderna worth $18.7M as of Q1 2026.
  • Moderna was a new HRT Financial position in Q1 2026.
  • Moderna made up 0.05% of HRT Financial's portfolio in Q1 2026, its #357 holding.
  • HRT Financial first reported a position in Moderna in Q3 2020 and has held it in 11 quarters since.
  • HRT Financial's Moderna position peaked at $140M in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.